Newborn Screening
Newborn Screening Testing at SHL
The State Hygienic Laboratory is CLIA accredited to perform laboratory screening tests for over 50 inherited genetic/metabolic conditions on all infants born in Iowa. The laboratory works round the clock, 365 days a year to ensure that conditions are identified, and lifesaving treatments can be provided so that babies can thrive. SHL partners with the University of Iowa Stead Family Children’s Hospital, for provider consultation, genetic counseling, and follow-up services.
-
Screening tests may identify increased risk for the following conditions: amino acid disorders, biotinidase deficiency, congenital adrenal hyperplasia, cystic fibrosis, fatty acid oxidation disorders, galactosemia, hemoglobinopathies, hypothyroidism, Pompe Disease, Mucopolysaccharidosis Type 1, and X-linked Adrenoleukodystrophy, and organic acid disorders.
-
The child's licensed health-care provider will be informed when the tests are completed and if results warrant further
Collection Instructions
Newborn Screening Results Reports and Updated EMR Results Specifications
Below are examples of the new version of the Lysosomal Storage Disorder test results reports and updated EMR results specifications beginning on August 1, 2025.
Newborn Screening Lysosomal Storage Disorder Test Changes
Iowa
LSD Iowa test with Presumptive Positive interpretations
LSD Iowa test with Borderline Pompe interpretation
Newborn Screening Results Specifications Iowa 2025
North Dakota
LSD ND test with Presumptive Positive interpretations
LSD ND test with Borderline Pompe interpretation
Newborn Screening Results Specifications North Dakota 2025
South Dakota
LSD SD test with Presumptive Positive Pompe interpretation